ORGO Earnings

Quarterly EPS
$-0.13
Q2 2024
$0.09
Q3 2024
$0.05
Q4 2024
$-0.17
Q1 2025
$-0.10
Q2 2025
$0.11
Q3 2025
$0.28
Q4 2025
$-0.44
Q1 2026
Latest Revenue37.2M
Latest Net Income-53156000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q1 2026-$0.4437.2M-53156000-57.1%-158.8%
Q4 2025$0.28225.6M43.7M+78.1%+460.0%
Q3 2025$0.11150.9M21.6M+31.0%+22.2%
Q2 2025-$0.10101.0M-9392000-22.4%+23.1%
Q1 2025-$0.1786.7M-18843000-21.2%-750.0%
Q4 2024$0.05126.7M7.7M+27.1%
Q3 2024$0.09115.2M12.3M+6.1%+350.0%
Q2 2024-$0.13130.2M-17043000+11.0%-425.0%
Q1 2024-$0.02110.0M-2100000
Q4 2023$0.0099.7M-568000
Q3 2023$0.02108.5M3.2M
Q2 2023$0.04117.3M5.3M
Organogenesis (ORGO) — Earnings